Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Forward Pharma Ads (FWP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Forward Pharma Appeals the Decision of the Opposition Division to Revoke the EP2801355 Patent

Forward Pharma A/S (Nasdaq:FWP) ("We" or "Forward" or the "Company"), today announced the filing of a notice of appeal of the decision of the Opposition Division of the European Patent Office (the "EPO")...

FWP : 3.11 (+6.51%)
Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference

Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Dr. Claus Bo Svendsen, the Company's Chief Executive Officer, will give a corporate update at the 7th Annual Leerink Partners Global...

FWP : 3.11 (+6.51%)
Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent

Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company") today announced that the European Patent Office (the "EPO") has revoked the EP2801355 patent (the "'355 patent") following the oral hearing...

FWP : 3.11 (+6.51%)
Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit

Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company") today announced the filing of its reply brief to the U.S. Court of Appeals for the Federal Circuit (the "Federal Circuit") in the appeal of...

FWP : 3.11 (+6.51%)
Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018

Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company") today announced the filing of further written submissions in the European Opposition Proceeding for the EP2801355 patent ("the '355 patent")...

FWP : 3.11 (+6.51%)
Forward Pharma to Participate in Investor Conferences in December

Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Dr. Claus Bo Svendsen, the Company's Chief Executive Officer, will participate in two upcoming investor conferences in New York, NY....

FWP : 3.11 (+6.51%)
Forward Pharma Announces Completion of Corporate Restructuring Plan

Forward Pharma A/S (NASDAQ:FWP) ("Forward Pharma") today announced the completion of its previously announced corporate restructuring plan (the "Restructuring") substantially in the form set forth in Appendix...

FWP : 3.11 (+6.51%)
Forward Pharma to Participate in the Nordic-American Life Science Conference

Forward Pharma A/S (NASDAQ:FWP) (the "Company") today announced that Dr. Claus Bo Svendsen, the Company's Chief Executive Officer, will participate in the Nordic-American Life Science Conference being...

FWP : 3.11 (+6.51%)
Featured Company News - AVEO Declares Completion of TIVO-3 Study Futility Analysis

Research Desk Line-up: Forward Pharma Post Earnings Coverage

AVEO : 2.28 (-2.98%)
FWP : 3.11 (+6.51%)
Biotechs Ramp up Clinical Trial Programs as FDA Looks at More Efficient Drug Development Programs

PALM BEACH, Florida, September 13, 2017 /PRNewswire/ --

ALDX : 8.73 (+0.29%)
TEVA : 21.63 (+2.27%)
FWP : 3.11 (+6.51%)
MRNS : 6.02 (+15.11%)
MBRX : 1.69 (+4.97%)
Biotechs Ramp up Clinical Trial Programs as FDA Looks at More Efficient Drug Development Programs

The hope of new measures for the FDA to advance the regulatory path for drug development is forging ahead incorporating relatively swift pivotal data in seeking accelerated approvals. FDA commissioner...

ALDX : 8.73 (+0.29%)
TEVA : 21.63 (+2.27%)
FWP : 3.11 (+6.51%)
MRNS : 6.02 (+15.11%)
MBRX : 1.69 (+4.97%)
Today's Research Reports on Stocks to Watch: Atossa Genetics and Forward Pharma

NEW YORK, NY / ACCESSWIRE / September 13, 2017 / Shares of Forward Pharma saw an explosive gain on Tuesday despite any significant news from the company yesterday. Shares of Atossa Genetics also saw significant...

ATOS : 3.20 (-4.48%)
FWP : 3.11 (+6.51%)
Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit

Forward Pharma A/S (NASDAQ:FWP) ("Forward" or the "Company") today announced the filing in the U.S. Court of Appeals for the Federal Circuit (the "Federal Circuit") of the opening brief for the appeal...

FWP : 3.11 (+6.51%)
Forward Pharma Board of Directors Approves Capital Reduction and Returns EUR 917.7 Million to Shareholders

Forward Pharma A/S (NASDAQ:FWP) ("the Company" or "Forward") today announced the final approval by the Company's board of directors of the plans to return a total of EUR 917.7 million to its shareholders...

BK : 57.24 (-0.37%)
FWP : 3.11 (+6.51%)
Forward Pharma announces planned distribution of EUR 19.45 per share to Shareholders

Forward Pharma A/S (NASDAQ:FWP) ("the Company" or "Forward") today announced plans to return EUR 19.45 per share amounting to a total of EUR 917.7 million to its shareholders through a capital reduction....

FWP : 3.11 (+6.51%)

Van Meerten Stock Picks

5 Great Growth Stocks
This morning I wanted to find 5 stocks that were predicted to have double digit growth in both Revenue and Earnings over the next 5 years that were also having great current performance.
LULU +1.14 , ABMD -1.06 , AAXN +2.28 , NSP +0.90 , ERI +1.00
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Free Commodities Newsletter

Get prepared for your trading day with

Barchart's Commodity Futures Morning Update Email

InsideFutures Commentary

InsideFutures weekly newsletter features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Friday morning to your inbox.

Brugler Ag Report

Today's Commentary

Corn futures were weak into the close on Thursday, down 3 to 4 1/4 cents lower in the front months. Traders were taking money off the table ahead of the extended weekend. The USDA reported a private cancelation of 132,000 of grain sorghum to unknown ...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar